Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: only for patent 584 which is infringed by ARM
You probably opened a can of worms. They way I read that EE Times article, the J3 are claimed to infringe on all three patents. All ARM licensees, which include the J3, are claimed to be infringing on 584. And while the trial is only about the J3, if they lose on the 584 patent, then that has significant rammifications. Am I reading this correctly??
Share
New Message
Please login to post a reply